Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed

Medtronic plc, has received U.S. FDA 510(k) clearance of the NIM Vital™ nerve monitoring system, which enables physicians to identify, … continue reading “Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed”

Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months

Statistically significant 12-month results from a large, multicenter randomized controlled trial confirm 84% Back Pain Responder Rate and 69% Profound … continue reading “Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months”

Medtronic Launches Adaptix™ Interbody System, First Navigated Titanium Cage with Titan nanoLOCK™ Surface Technology

Medtronic plc, has chosen the North American Spine Society (NASS) annual meeting at which to announce the U.S. launch of … continue reading “Medtronic Launches Adaptix™ Interbody System, First Navigated Titanium Cage with Titan nanoLOCK™ Surface Technology”

Medtronic Submits InterStim™ Micro Neurostimulator and SureScan™ MRI Leads to FDA

Medtronic plc tells us it has filed a pre-market approval (PMA) supplement with the U.S. FDA for approval of its … continue reading “Medtronic Submits InterStim™ Micro Neurostimulator and SureScan™ MRI Leads to FDA”